Carpal tunnel syndrome: a common initial symptom of systemic wild-type ATTR (ATTRwt) amyloidosis

References

• Westermark P, Sletten K, Johansson B, Cornwell GG. III Fibril in senile systemic amyloidosis is derived from normal transthyretin. Proc Natl Acad Sci USA 1990;87:2843–5
   PubMed Web of Science ®Google Scholar
• Cornwell GG, III Murdoch WL, Kyle RA, Westermark P, Pitkanen P. Frequency and distribution of senile cardiovascular amyloid. A clinicopathologic correlation. Am J Med 1983;75:618–23
   PubMed Web of Science ®Google Scholar
• Tanskanen M, Kiuru-Enari S, Tienari P, Polvikoski T, Verkkoniemi A, Rastas S, Sulkava R, et al. Senile systemic amyloidosis, cerebral amyloid angiopathy, and dementia in a very old finnish population. Amyloid 2006;13:164–9
   PubMed Web of Science ®Google Scholar
• Ueda M, Horibata Y, Shono M, Misumi Y, Oshima T, Su Y, Tasaki M, et al. Clinicopathological features of senile systemic amyloidosis: an ante- and postmortem study. Mod Pathol 2011;24:1533–44
   PubMed Web of Science ®Google Scholar
• Berk JL, Suhr OB, Obici L, Sekijima Y, Zeldenrust SR, Yamashita T, Heneghan MA, et al. Repurposing diflunisal for familial amyloid polyneuropathy: a randomized clinical trial. JAMA 2013;310:2658–67
   PubMed Web of Science ®Google Scholar
• Coelho T, Maia LF, Martins da Silva A, Waddington Cruz M, Plante-Bordeneuve V, Lozeron P, Suhr OB, et al. Tafamidis for transthyretin familial amyloid polyneuropathy: a randomized, controlled trial. Neurology 2012;79:785–92
   PubMed Web of Science ®Google Scholar
• Ackermann EJ, Guo S, Booten S, Alvarado L, Benson M, Hughes S, Monia BP. Clinical development of an antisense therapy for the treatment of transthyretin-associated polyneuropathy. Amyloid 2012;19:43–4
   PubMed Web of Science ®Google Scholar
• Coelho T, Adams D, Silva A, Lozeron P, Hawkins PN, Mant T, Perez J, et al. Safety and efficacy of rnai therapy for transthyretin amyloidosis. N Engl J Med 2013;369:819–29
   PubMed Web of Science ®Google Scholar
• Hoshii Y, Setoguchi M, Iwata T, Ueda J, Cui D, Kawano H, Gondo T, et al. Useful polyclonal antibodies against synthetic peptides corresponding to immunoglobulin light chain constant region for immunohistochemical detection of immunoglobulin light chain amyloidosis. Pathol Int 2001;51:264–70
   PubMed Web of Science ®Google Scholar
• Imada N. Pathological study on amyloidosis. Isolation and purification of amyloid fibril protein and biochemical and immunological analysis. Yamaguchi Med J 1981;30:149–62
   Google Scholar
• Gustavsson A, Engstrom U, Westermark P. Mechanisms of transthyretin amyloidogenesis. Antigenic mapping of transthyretin purified from plasma and amyloid fibrils and within in situ tissue localizations. Am J Pathol 1994;144:1301–11
   PubMed Web of Science ®Google Scholar
• Ng B, Connors LH, Davidoff R, Skinner M, Falk RH. Senile systemic amyloidosis presenting with heart failure: a comparison with light chain-associated amyloidosis. Arch Intern Med 2005;165:1425–9
   PubMed Web of Science ®Google Scholar
• Rapezzi C, Merlini G, Quarta CC, Riva L, Longhi S, Leone O, Salvi F, et al. Systemic cardiac amyloidoses: disease profiles and clinical courses of the 3 main types. Circulation 2009;120:1203–12
   PubMed Web of Science ®Google Scholar
• Ruberg FL, Berk JL. Transthyretin (TTR) cardiac amyloidosis. Circulation 2012;126:1286–300
   PubMed Web of Science ®Google Scholar
• Kodaira M, Sekijima Y, Tojo K, Tsuchiya A, Yazaki M, Ikeda S, Hoshii Y, et al. Non-senile wild-type transthyretin systemic amyloidosis presenting as bilateral carpal tunnel syndrome. J Peripher Nerv Syst 2008;13:148–50
   PubMed Web of Science ®Google Scholar
• Westermark P, Bergstrom J, Solomon A, Murphy C, Sletten K. Transthyretin-derived senile systemic amyloidosis: clinicopathologic and structural considerations. Amyloid 2003;10:48–54
   PubMed Web of Science ®Google Scholar
• Pitkanen P, Westermark P, Cornwell GG. III Senile systemic amyloidosis. Am J Pathol 1984;117:391–9
   PubMed Web of Science ®Google Scholar
• Sekijima Y, Uchiyama S, Tojo K, Sano K, Shimizu Y, Imaeda T, Hoshii Y, et al. High prevalence of wild-type transthyretin deposition in patients with idiopathic carpal tunnel syndrome: a common cause of carpal tunnel syndrome in the elderly. Hum Pathol 2011;42:1785–91
   PubMed Web of Science ®Google Scholar
• Sueyoshi T, Ueda M, Jono H, Irie H, Sei A, Ide J, Ando Y, et al. Wild-type transthyretin-derived amyloidosis in various ligaments and tendons. Hum Pathol 2011;42:1259–64
   PubMed Web of Science ®Google Scholar
• Takanashi T, Matsuda M, Yazaki M, Yamazaki H, Nawata M, Katagiri Y, Ikeda S. Synovial deposition of wild-type transthyretin-derived amyloid in knee joint osteoarthritis patients. Amyloid 2013;20:151–5
   PubMed Web of Science ®Google Scholar
• Yanagisawa A, Ueda M, Sueyoshi T, Okada T, Fujimoto T, Ogi Y, Kitagawa K, et al. Amyloid deposits derived from transthyretin in the ligamentum flavum as related to lumbar spinal canal stenosis. Mod Pathol 2015;28:201–7
   PubMed Web of Science ®Google Scholar
• Westermark P, Westermark GT, Suhr OB, Berg S. Transthyretin-derived amyloidosis: probably a common cause of lumbar spinal stenosis. Ups J Med Sci 2014;119:223–8
   PubMed Web of Science ®Google Scholar
• Kyle RA, Gertz MA, Linke RP. Amyloid localized to tenosynovium at carpal tunnel release. Immunohistochemical identification of amyloid type. Am J Clin Pathol 1992;97:250–3
   PubMed Web of Science ®Google Scholar
• Takei Y, Hattori T, Gono T, Tokuda T, Saitoh S, Hoshii Y, Ikeda S. Senile systemic amyloidosis presenting as bilateral carpal tunnel syndrome. Amyloid 2002;9:252–5
   PubMed Web of Science ®Google Scholar
• Takei Y, Hattori T, Tokuda T, Matsuda M, Saitoh S, Hoshii Y, Ikeda S. Senile systemic amyloidosis starting as bilateral carpal and left ulnar tunnel syndrome. Intern Med 2003;42:1050–1
   PubMed Web of Science ®Google Scholar
• Stein K, Storkel S, Linke RP, Goebel HH. Chemical heterogeneity of amyloid in the carpal tunnel syndrome. Virchows Arch a Pathol Anat Histopathol 1987;412:37–45
   PubMedGoogle Scholar
• Nakamichi KI, Tachibana S. Amyloid deposition in the synovium and ligament in idiopathic carpal tunnel syndrome. Muscle Nerve 1996;19:1349–51
   PubMed Web of Science ®Google Scholar
• Longhi S, Quarta CC, Milandri A, Lorenzini M, Gagliardi C, Manuzzi L, Bacchi-Reggiani ML, et al. Atrial fibrillation in amyloidotic cardiomyopathy: prevalence, incidence, risk factors and prognostic role. Amyloid 2015;22:147–55
   PubMed Web of Science ®Google Scholar
• Dubrey S, Pollak A, Skinner M, Falk RH. Atrial thrombi occurring during sinus rhythm in cardiac amyloidosis: evidence for atrial electromechanical dissociation. Br Heart J 1995;74:541–4
   PubMedGoogle Scholar
• Santarone M, Corrado G, Tagliagambe LM, Manzillo GF, Tadeo G, Spata M, Longhi M. Atrial thrombosis in cardiac amyloidosis: diagnostic contribution of transesophageal echocardiography. J Am Soc Echocardiogr 1999;12:533–6
   PubMed Web of Science ®Google Scholar
• Kyle RA, Spittell PC, Gertz MA, Li CY, Edwards WD, Olson LJ, Thibodeau SN. The premortem recognition of systemic senile amyloidosis with cardiac involvement. Am J Med 1996;101:395–400
   PubMed Web of Science ®Google Scholar
• Ikeda S, Sekijima Y, Tojo K, Koyama J. Diagnostic value of abdominal wall fat pad biopsy in senile systemic amyloidosis. Amyloid 2011;18:211–15
   PubMed Web of Science ®Google Scholar
• Takashio S, Izumiya Y, Jinnin M, Yamamuro M, Kojima S, Ihn H, Ogawa H. Diagnostic and prognostic value of subcutaneous tissue biopsy in patients with cardiac amyloidosis. Am J Cardiol 2012;110:1507–11
   PubMed Web of Science ®Google Scholar